Skip to main content
Equibles
OPK logo

OPK · Opko Health, Inc. · Metrics

Track OPK — free

Use OPK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OPK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.66 +0.00 (+0.00%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.24B
Shares
746.33M
Volume · Oct 20 4.35M Avg daily vol (3M) 4.23M

OPK metrics

95 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.66
Market cap
$1.24B

Price action

20 metrics
Price change (1W)
+25.8%
Price change (30D)
-1.8%
Price change (3M)
+37.2%
Price change (6M)
+36.1%
Price change (YTD)
+31.7%
Price change (1Y)
+8.5%
Trailing year
Price change (5Y)
-55.4%
52-week high
$1.73
52-week low
$1.10
Change from 52-week high
-4.0%
Change from 52-week low
+50.9%
Annualized volatility
57.9%
Annualized volatility (3M)
93.9%
Beta
0.9
RSI (14D)
59.7
Price vs SMA 50
+8.7%
Price vs SMA 200
+24.6%
Avg volume (3M)
4.23M
Relative volume
1.0
Average dollar volume
$6.46M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
746.33M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.5×
reciprocal yield 65.1%
EV / EBITDA
21.8×
reciprocal yield 4.6%
EV / EBIT
—
P / sales
2.0×
reciprocal yield 48.9%
P / book
1.0
reciprocal yield 98.6%
FCF yield
-11.2%
TTM · current market cap
Buyback yield
3.9%
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.1×
reciprocal yield 92.0%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 86.7%
EV / EBIT historical average (3Y)
49.1×
reciprocal yield 2.0%
EV / EBIT historical average (5Y)
49.1×
reciprocal yield 2.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
15.8×
reciprocal yield 6.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-27

Profitability

9 metrics
Gross margin
40.8%
Operating margin
-8.2%
Trailing 12 months
Net margin
-12.4%
Gross profit (TTM)
$239.69M
Operating profit (TTM)
−$48.25M
Net income (TTM)
−$72.89M
Trailing 12 months
Diluted EPS (TTM)
$-0.09
FCF margin
-22.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.77
Gross profit per diluted share (TTM)
$0.31
Operating profit per diluted share (TTM)
$-0.07
EBITDA per diluted share (TTM)
$0.05
Net income per diluted share (TTM)
$-0.10
Operating cash flow per diluted share (TTM)
$-0.16
Free cash flow per diluted share (TTM)
$-0.18
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.16
Stock compensation per diluted share (TTM)
$0.01
Book value per share
$0.60

Growth

11 metrics
Revenue growth YoY
+4.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$587.90M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
-15.5%
Revenue CAGR (5Y)
-15.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-6.2%
Return on assets
-4.0%
Debt / equity
0.0
Current ratio
3.3
EBITDA (TTM)
$41.47M
Free cash flow (TTM)
−$134.02M
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
-7.2
Return on invested capital
—
Trailing 12 months
Net cash
$298.07M
Latest balance sheet
Cash & equivalents
$300.76M
Total assets
$1.83B
Total debt
$2.69M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$123.38M
Capital expenditures (TTM)
$10.64M
R&D (TTM)
$125.22M
SG&A (TTM)
$205.85M
Stock compensation (TTM)
$10.83M
R&D / revenue
21.3%
Stock compensation / revenue
1.8%

Ownership (13F)

9 metrics
13F filers
224
13F filer change QoQ
-13
Institutional ownership
27.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
9.3%
Private-fund adviser ownership
9.1%
Active holders' share change QoQ
-1.8%
Holder tenure
12.7
Price vs estimated holder cost
+13.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.1%

Short interest

3 metrics
Short interest
4.8%
Latest settlement · 14.9 days to cover
Days to cover
14.9d
Short-squeeze score
86 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 944809 CUSIP 68375N103 13F (30d) 21 filings 21 filers Visit website Investor relations